Compile Data Set for Download or QSAR
Report error Found 84 of ic50 for UniProtKB: P03367
TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126682(US8785638, 170)
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126676(US8785638, 161)
Affinity DataIC50: 55.4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98672(US8497270, 35)
Affinity DataIC50: 200nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98668(US8497270, 29)
Affinity DataIC50: 250nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98669(US8497270, 30)
Affinity DataIC50: 360nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126692(US8785638, 190)
Affinity DataIC50: 370nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126690(US8785638, 186)
Affinity DataIC50: 430nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126634(US8785638, 116)
Affinity DataIC50: 620nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126631(US8785638, 142 | US8785638, 113)
Affinity DataIC50: 750nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126635(US8785638, 117)
Affinity DataIC50: 780nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98665(US8497270, 24)
Affinity DataIC50: 950nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126632(US8785638, 114)
Affinity DataIC50: 1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126679(US8785638, 165)
Affinity DataIC50: 1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126685(US8785638, 175)
Affinity DataIC50: 1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98667(US8497270, 28)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126630(US8785638, 112)
Affinity DataIC50: 1.11E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98670(US8497270, 31)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126683(US8785638, 171)
Affinity DataIC50: 1.21E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126666(US8785638, 150)
Affinity DataIC50: 1.37E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126677(US8785638, 162)
Affinity DataIC50: 1.57E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98671(US8497270, 32)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126664(US8785638, 148)
Affinity DataIC50: 2.19E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM97447(Aspartyl protease inhibitor, 13)
Affinity DataIC50: 2.20E+3nMpH: 5.5Assay Description:Binding constants for inhibition of HIV protease were determined as previously described.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2013
Entry Details Article
PubMed
TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126637(US8785638, 119)
Affinity DataIC50: 2.66E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126638(US8785638, 120)
Affinity DataIC50: 2.72E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126643(US8785638, 127)
Affinity DataIC50: 2.85E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126680(US8785638, 166)
Affinity DataIC50: 3.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126639(US8785638, 122)
Affinity DataIC50: 3.20E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM97448(Aspartyl protease inhibitor, 14)
Affinity DataIC50: 3.30E+3nMpH: 5.5Assay Description:Binding constants for inhibition of HIV protease were determined as previously described.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2013
Entry Details Article
PubMed
TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126689(US8785638, 184)
Affinity DataIC50: 3.44E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126629(US8785638, 110)
Affinity DataIC50: 4.31E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126652(US8785638, 136)
Affinity DataIC50: 4.34E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126627(US8785638, 108)
Affinity DataIC50: 4.48E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126678(US8785638, 163)
Affinity DataIC50: 4.50E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126647(US8785638, 131)
Affinity DataIC50: 4.54E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126662(US8785638, 146)
Affinity DataIC50: 4.76E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126684(US8785638, 173)
Affinity DataIC50: 5.90E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126622(US8785638, 100)
Affinity DataIC50: 6.61E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126660(US8785638, 144)
Affinity DataIC50: 6.64E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126628(US8785638, 109)
Affinity DataIC50: 6.81E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126631(US8785638, 142 | US8785638, 113)
Affinity DataIC50: 7.43E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126649(US8785638, 133)
Affinity DataIC50: 7.80E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126687(US8785638, 181)
Affinity DataIC50: 8.06E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126669(US8785638, 154)
Affinity DataIC50: 8.12E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126655(US8785638, 139)
Affinity DataIC50: 9.24E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126644(US8785638, 128)
Affinity DataIC50: 1.13E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126686(US8785638, 177)
Affinity DataIC50: 1.17E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM97449(Aspartyl protease inhibitor, 15)
Affinity DataIC50: 1.21E+4nMpH: 5.5Assay Description:Binding constants for inhibition of HIV protease were determined as previously described.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2013
Entry Details Article
PubMed
TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126674(US8785638, 159)
Affinity DataIC50: 1.33E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126673(US8785638, 158)
Affinity DataIC50: 1.35E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

Displayed 1 to 50 (of 84 total ) | Next | Last >>
Jump to: